ALEXANDER LAZAR to Cyclin-Dependent Kinase Inhibitor p27
This is a "connection" page, showing publications ALEXANDER LAZAR has written about Cyclin-Dependent Kinase Inhibitor p27.
Connection Strength
0.034
-
Co-targeting PI3K, mTOR, and IGF1R with small molecule inhibitors for treating undifferentiated pleomorphic sarcoma. Cancer Biol Ther. 2017 10 03; 18(10):816-826.
Score: 0.034
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.